jenburkt-pharmaceuticals-ltd
Home
Jenburkt Pharmaceuticals Ltd
null Share Price
BSE:
NSE:
null Share Price
BSE:
NSE:
Pharmaceuticals
Small Cap
₹-
0 (0%)
Market Cap
₹579.16 Cr
PE Ratio
19.11
Jenburkt Pharmaceuticals Ltd Performance
▲
▲
▲
▲
Jenburkt Pharmaceuticals Ltd Fundamentals
Jenburkt Pharmaceuticals Ltd Delivery and Volume
About Jenburkt Pharmaceuticals Ltd
Jenburkt Pharmaceuticals Ltd, incorporated in 1985, was formed a venture to diversify into the healthcare and pharmaceutical industry, by Bhuta family. The Company is engaged in manufacturing and marketing of speciality and high quality pharmaceutical formulations and healthcare products.
Present
| Name | Designation |
|---|---|
| Ashish R Shah | Company Sec. & Compli. Officer |
| Ashish U Bhuta | Chairman & Managing Director |
| Dilip H Bhuta | Whole Time Director & CFO |
| Hina Ravindra Mehta | Non-Exec. & Independent Dir. |
| Sumit Ajaybhai Thakkar | Independent Director |
| KRISHNAN SUBHARAMAN | Independent Director |
| PANKAJ . | Independent Director |
News and Events...
Top Gainers Today
View All
Top Losers Today
View All
Jenburkt Pharmaceuticals Ltd FAQs
How do I Buy Jenburkt Pharmaceuticals Ltd Shares?
By opening a demat account and having your KYC papers confirmed online, you may simply purchase Jenburkt Pharmaceuticals Ltd shares in BlinkX.
What is the Share Price of Jenburkt Pharmaceuticals Ltd?
The share price of any stock is volatile and changes during the day due to a variety of variables. Jenburkt Pharmaceuticals Ltd's share price is ₹1312.3 as of 2024-12-14.
What is the PE ratio of Jenburkt Pharmaceuticals Ltd?
Jenburkt Pharmaceuticals Ltd's P/E ratio is 19.11 times as of 2024-12-14.
What is the PB ratio of Jenburkt Pharmaceuticals Ltd?
Jenburkt Pharmaceuticals Ltd's most recent financial reports indicate a price-to-book ratio of 3.67, showing the company's stock market valuation in relation to the value of its real assets.
What is the Market Cap of Jenburkt Pharmaceuticals Ltd?
Market capitalization, often known as market cap, is the market value of all outstanding shares of a publicly listed corporation. Jenburkt Pharmaceuticals Ltd's market capitalization is ₹579.16 Cr as on 2024-12-14.
What is the ROE of Jenburkt Pharmaceuticals Ltd?
The current financial records of Jenburkt Pharmaceuticals Ltd show a 19.44% ROE, showing great financial performance and effective capital utilisation, making it a significant statistic for investors.
What is the Total Asset of Jenburkt Pharmaceuticals Ltd?
According to Jenburkt Pharmaceuticals Ltd's most recent financial filings, the company has a total asset value of ₹112.11, which includes current and non-current assets such as inventory, cash, properties, and equipment.
What is the 52-week high and Low of Jenburkt Pharmaceuticals Ltd?
The 52-week high/low price of a Jenburkt Pharmaceuticals Ltd stock is the highest and lowest price at which it has traded over that period (about one year) and is used as a technical indicator. Jenburkt Pharmaceuticals Ltd's 52-week high and low as of 2024-12-14 are ₹1324.95 and ₹1250, respectively.
